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Failure to Detect Borna Disease Virus Antibody and   
RNA from Peripheral Blood Mononuclear Cells   
of Psychiatric Patients 
 
 
 
ObjectiveaaBorna disease virus (BDV) is a highly neurotropic agent causing various neu-
ropsychiatric symptoms in animals. Over the past two decades, it has been suggested that 
BDV might be associated with human psychiatric diseases. We aimed to investigate whe-
ther BDV is associated with psychiatric patients in Korea. 
MethodsaaWe recruited 60 normal controls and 198 psychiatric patients (98 patients with 
depressive disorder, 60 with schizophrenia, and 40 with bipolar disorder). We used an in-
direct immunofluorescence antibody (IFA) test for the BDV antibody and a real-time reverse 
transcriptase polymerase chain reaction (rRT-PCR) assay for p24 and p40 RNA from peri-
pheral blood mononuclear cells (PBMCs). 
ResultsaaNeither the BDV antibody nor p24, p40 RNA was detected in controls and patients 
groups. 
ConclusionaaOur results suggest that BDV might not be associated with psychiatric patients 
in Korea. 
   Psychiatry  Invest  2009;6:306-312
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Introduction 
 
It has been suggested that viruses may cause various psychiatric diseases such as
schizophrenia and mood disorders.
1 Borna disease virus (BDV) is one of the possi-
ble causative agents associated with psychiatric diseases. BDV is a highly neurotro-
pic RNA virus with an enveloped, nonsegmented, negative stranded RNA genome.
2-4
BDV has been known to naturally infect several animal species such as cattle, cats,
horses, and sheep.
5-8 
Animals infected with BDV show various neurobehavioral symptoms, such as hy-
peractivity, stereotyped behavior, anxiety, and abnormal social behaviors reminisc-
ent of symptoms observed in human psychiatric diseases.
9-11 BDV mainly infects the 
limbic system and cerebellum, which play an important role in the psychiatric dise-
ase.
12-14 Recent studies have further demonstrated evidence that BDV causes distur-
bances in the central nervous system.
15-17 
Based on those findings, several studies have been carried out to investigate whe-
ther BDV is associated with psychiatric diseases. Initially, Rott et al.
18 detected anti-
bodies against BDV mainly in mood disorder patients. With the knowledge of the
sequence and genomic organization of BDV, Bode et al.
19 first detected BDV RNA 
by reverse transcriptase polymerase chain reaction (RT-PCR) in various psychiatric  
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patients. Other investigators have revealed the possible 
relationship between BDV and human psychiatric dise-
ases in various regions such as Europe,
20-22 Brazil,
23,24 
and Japan.
13,25,26 However, due to the lack of reliable dia-
gnostic tools for BDV detection, subsequent studies could 
not replicate BDV-positive results (Table 1), and it re-
mains unclear whether BDV is associated with human 
psychiatric diseases.
27 
Recently, real time RT-PCR (rRT-PCR) has been pro-
ven to be an effective and convenient method in viral 
gene detection.
28,29 rRT-PCR has the advantage of avoid-
ing the contamination problem during the procedure, 
which is a drawback of nested RT-PCR.
30 Nested RT-
PCR comprises two consecutive rounds of PCR amplifi-
cation to improve sensitivity. Generally, those two PCR 
amplification process is performed in two tubes, which 
requires manual handling of amplicons. Also, to detect 
and prevent the contamination of complementary DNA 
(cDNA), both positive and negative controls are requir-
ed in each PCR rounds. Hence, the cross-contamination 
would occur between primary and secondary PCR. After 
the secondary PCR is finished, it is needed to transfer 
the nested PCR products to the agarose gel electropho-
resis to detect the products. This process also increases 
TABLE 1. Published studies of BDV detection by RT-PCR in neuropsychiatric samples of human peripheral blood 
Viral gene  Cell type (mL) Origin  Health  status  Positives  References 
p24, p40  PBMCs (9 mL) Germany  Various  diagnoses; healthy controls  4/6 (66.7%); 0/10 (0%) Bode  et  al.19 
p24 PBMCs  (unknown) Japan  Various  diagnoses; controls 22/60  (36.7%); 8/172 (4.6%)  Kishi et al.51,52 
p24 PBMCs 
(unknown) 
Japan Schizophrenia; depression; 
 healthy  controls 
5/49 (10.2%); 1/6 (16.7%); 
 0/36 (0%) 
Igata-Yi et al.47 
p24 PBMCs  (unknown)  Japan  Chronic fatigue syndrome  3/25 (12%) Nakaya  et  al.53 
p24, p40  PBMCs (15-20 mL) Germany  Various  diagnoses; healthy controls  13/26 (50%); 0/23 (0%) Sauder  et  al.46 
p24 Whole  blood 
(unknown) 
Japan Schizophrenia; medical staff  6/61 (9.8%); 0/26 (0%) Iwahashi  et  al.54 
p24 PBMCs  (7-10 mL)  Japan  Various diagnoses; health controls  2/106 (1.9%); 0/12 (0%) Kubo  et  al.55 
p24 PBMCs  (unknown) Japan  Blood  donors  4/7  (57.1%)  Takahashi et al.56 
p40 Whole  blood 
(5 mL) 
Germany Various  diagnoses  0/159  (0%)  Lieb et al.41 
p24, p40  PBMCs 
(10-20 mL) 
USA, 
 Germany 
Various diagnoses; 
healthy controls 
0/52 (0%); 0/14 (0%)  Richt et al.40 
p24 PBMCs 
(15 mL) 
Japan Schizophrenia; mood disorder; 
 healthy  controls 
2/49 (4.1%); 3/77 (3.9%); 
 2/84 (2.4%) 
Iwata et al.57 
p24, p40  Whole blood 
(unknown) 
Germany  Schizophrenia for 8 months  1/1  Planz et al.58 
p40 Granulocytes 
(5 mL) 
Germany Schizophrenia; mood disorder; 
 healthy  controls 
1/1; 2/2; 0/3 (0%) Planz  et  al.59 
p24 PBMCs 
(10 mL) 
Taiwan Schizophrenia; healthy controls; 
  mental health workers 
10/74 (13/5%); 1/69 (1.4%); 
 7/45 (15.5%) 
Chen et al.60 
p24 PBMCs  (unknown) Korea  Various  diagnoses  0/81  (0%)  Kim et al.38 
p40 PBMCs 
(5×106 cells) 
Switzerland Various  neurological disorders  0/27 (0%) Bachmann  et  al.39
p24 PBMCs  (unknown)  Japan  Two families with CSF  6/10 (60%) Nakaya  et  al.61 
p24, p40  PBMCs (35 mL)  Sweden  Chronic fatigue syndrome  0/18 (0%) Evengard  et  al.62 
p24, p40, 
gp18 
PBMCs 
(unknown) 
Austria  Chronic fatigue syndrome  1/1  Nowotony and 
 Kolodziejek63 
p24, p40  PBMCs 
(unknown) 
Japan Various  diagnoses; 
healthy controls 
1/56 (0.6%); 1/173 (0.6%)  Tsuji et al.42 
p24 PBMCs 
(2×105 cells) 
Japan Mood  disorder; schizophrenia; 
 healthy  controls 
1/45; 0/45; 0/45  Fukuda et al.64 
p24, p40  PBMCs (10 mL) Korea  Schizophrenia  0/60  (0%)  Kim et al.65 
p24 PBMCs 
(unknown) 
Brazil  Mood and psychotic disorders; 
 healthy  controls 
10/30 (33.33%); 4/30 (13.3%) Miranda  et  al.23 
p24 PBMCs 
(10 mL) 
Brazil  Schizophrenia and schizaffective 
 disorder; healthy controls; 
  relatives without psychiatric 
 disorders; relatives with 
 mood  disorders 
12/27 (44.4%); 4/27 (14.8%); 
 10/20 (50.0%); 9/24 (37.5%) 
Nunes et al.24 
p24 PBMCs  (10-20 mL) China  Neurological  disorders  6/65  (9.2%)  Li et al.66 
This Table is modified from <Table 1, studies aimed at detecting BDV by RT-PCR in samples of human peripheral blood>67. BDV: Borna 
disease virus, RT-PCR: reverse transcriptase polymerase chain reaction, PBMCs: peripheral blood mononuclear cells    
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the risk of contamination. However, in the case of rRT-
PCR, the risk of contamination is low because both the 
PCR and detection of the products are performed in a 
sealed system without handling of amplicons. Several 
studies have established the sensitivity and specificity of 
rRT-PCR for the detection of BDV genes.
31,32 Hence, we 
used rRT-PCR to investigate BDV infection in psy-
chiatric patients. To our knowledge, it is the first study 
to examine BDV RNA in psychiatric patients by rRT-
PCR. Considering some evidence indicating discrepan-
cies between serologic studies and rRT-PCR results,
33 
we used both an indirect immunofluorescence antibody 
(IFA) test and rRT-PCR to compare the results of the two 
methods. This study investigated BDV RNA and BDV 
antibody using rRT-PCR and indirect IFA test from peri-
pheral blood mononuclear cells of psychiatric patients in 
Korea. 
 
Methods 
 
Subjects 
During January 2004 and December 2007, 198 psychia-
tric patients and 60 normal controls were recruited. All 
the patients were newly admitted in closed wards of the 
Department of Psychiatry, Ansan Hospital. Of the 198 
patients, 98 patients had major depressive disorder, 60 
had schizophrenia, and 40 had bipolar disorder. All the 
patients were interviewed by structured diagnostic cri-
teria categorized according to the criteria of the fourth 
edition of the American Psychiatric Association.
34 All the 
patients had active symptoms at the time of enrollment. 
Sixty normal controls were randomly selected among 
healthy individuals visiting the same hospital for regular 
health screens. All the patients and controls gave inform-
ed consent after a complete description of the study. The 
study protocol was approved by the Ethics Committee of 
Korea University. 
 
Preparation of peripheral blood mononuclear 
cells 
A sample of fasting blood (20 mL) was drawn from 
each of the 198 patients and 60 controls. Preparation of 
peripheral blood mononuclear cells (PBMCs) were iso-
lated from anticoagulant-treated blood by Ficoll-hypaque 
gradient centrifugation. Total RNA was extracted from 
PBMCs using RNAzol (Gibco/BRL, Gaithersburg, MD, 
USA). 
 
Serological detection of Borna disease virus 
infection with an indirect immunofluorescent 
antibody test 
An indirect IFA test was conducted according to the 
method previously described.
18 The Madine Darby canine 
kidney (MDCK) cell line and MDCK cell line persis-
tently infected with BDV (MDCK-BDV)35 cultured for 
five days with Dulbecco’s Modified Eagle Medium (DM-
EM)(Gibco/BRL, Germany) supplemented with 10% fe-
tal bovine serum (FBS)(Gibco/BRL, Germany) were try-
psinized, suspended in phosphate buffered saline (PBS), 
spotted onto Teflon-coated 10-well slides, and air-dried 
in room temperature. Cells on the 10-well antigen slide 
were fixed with anhydrous acetone at -20℃ for  7  minu-
tes and dried. Human and horse serum samples diluted 
in PBS as 1 : 32 were treated to the MDCK cell and MD-
CK-BDV cell on the antigen slide, and the slide was in-
cubated in a humidity chamber at 37℃ for 30 minutes. 
After three washes with PBS, Fluorescein isothiocyanate 
(FITC) conjugated anti-human immunoglobulin goat IgG 
(MP Biomedicals Inc., USA) was added to each well, 
and the slide was incubated in the humidity chamber at 
37℃ for 30 minutes. The slides were mounted with gly-
cine-buffered glycerol under cover slips and examined for 
a characteristic cytoplasmic fluorescent pattern with a flu-
orescence microscope. 
 
Genetic detection of viral genomic RNA with 
real-time reverse transcription-polymerase 
chain reaction 
Real-time quantitative RT-PCR for nucleoprotein (p40) 
and phosphoprotein (p24) genes of BDV was performed 
to detect the RNA genome of BDV in PBMCs. TaqMan 
probes were labeled with 6-carboxy fluorescein (FAM) 
as the 5’ fluorescent reporter and tetramethylrhodamine 
(TAMRA) as the 3’ quencher. The primers and probes were 
made as follows, in accordance with the previous report:36 
 
p40 forward primer:  
5’-TTTCATACAGTAACGCCCAGCC-3’ 
p40 reward primer: 
5’-GGCGTCGACAGGTAAGATTCA-3’ 
p40 probe: 
5’-FAM-TGAACAAACGCAGCGTGCAGTCCT- 
TAMRA-3’ 
p24 forward primer: 
5’-ATGCATTGACCCAACCGGTA-3’ 
p24 reward primer: 
5’-ATCATTCGATAGCTGCTCCCTTC-3’ 
p24 probe: 
5’-FAM-AGAACCCCTCCATGATCTCAGACCC 
AGA-TAMRA-3’ 
 
For the construction of the quantitative standard, the 
p40 and p24 genes were amplified by RT-PCR and clon-
ed to pGEM-T Easy vector system (Promega, USA). PCR  
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primers were made as follows: 
 
p40-BV259F: 
5’-TTCATACAGTAACGCCCAGC-3’ 
p40-BV829R: 
5’-GCAACTACGGGGATTGTAAGGG-3’ 
p40-OSX458:  
5’-ATGCATTGACCCAACCAGTA-3’ 
p24-OSX459: 
5’-GTCCCATTCATCCGTTGTC-3’ 
 
Cloned p40 and p24 genes were transcribed to RNA 
using the MEGAscript T7 transcription kit (Ambion Inc., 
USA) in accordance with the manufacturer’s instruc-
tions. A reverse transcription reaction was performed on 
the final 1×10
10 copies of cDNA per 1 μL using the p40-
F and p24-F primers. The cDNA mixtures were diluted 
by the 10-fold dilution method until 1×10
3 copies of 
cDNA per 1 μL were obtained. The real-time PCR reac-
tion mixture consisted of the Taqman Universal PCR 
Master Mix (Applied Biosystems, USA), as recommend-
ed in the manufacturer’s instructions. The real-time PCR 
reaction mixtures were incubated for 10 minutes at 95℃, 
and 40 cycles of amplification were performed using the 
ABI PRISM 7000 Sequence Detection System (Applied 
Biosystems, USA), each cycle consisting of a denatur-
ation step (15 seconds at 95℃) and an annealing-el-
ongation step (1 minute at 60℃). The threshold cycle 
(Ct) values, or the number of cycles for fluorescence to 
reach clearly detectable levels, a value greater than 40 
was regarded as a negative result (Table 2). 
 
Statistical analysis 
To analyze the demographic data, a two-tailed t-test 
was used for continuous covariates. For discrete covari-
ates, a chi-square test was used. The null hypothesis was 
rejected at p<0.05. The statistical package used for the 
analysis was Statistical Package for Social Science (SP-
SS; SPSS Inc, Chicago, IL, USA) 11.01. 
 
Results 
 
Demographic data 
Normal controls and psychiatric patients were compar-
ed on age and sex (Table 3). There was no significant 
difference in the male/female ratio between the controls 
and patients groups. However, the controls were signifi-
cantly older than the patients (p=0.009).  
 
Immunofluorescence antibody and real-time 
reverse transcriptase polymerase chain reaction 
p24 and p40 RNA were not detected by rRT-PCR in 
the controls and patients. In addition, the BDV antibody 
was not detected by the IFA in either group.   
 
Discussion 
 
In this study, we failed to detect the BDV antibody or 
RNA from peripheral blood mononuclear cells (PBMC) 
in psychiatric patients. Due to no evidence of BDV in-
fection, we could not compare the results of the IFA and 
rRT-PCR. Including our previous studies,
37,38 there have 
been several studies suggesting a dissociation between 
BDV and human psychiatric diseases.
33,39-42 
There are several possible reasons for these contro-
versial results. First, positive results might have been in-
duced by laboratory artifacts such as contamination. As 
mentioned before, nested RT-PCR is prone to contami-
nation during procedures. It has been suggested that BDV 
sequences found in human samples are very similar to 
the laboratory strains.
43,44 Recently, in a meta-analytic 
study, Dürrwald et al.
45 suggested that all the studies 
with BDV-positive results by nested RT-PCR might have 
TABLE 2. Threshold cycle (Ct) values in rRT-PCR assay
Quantitative standard  Ct value for p40  Ct value for p24
1×108  12.6 10.6 
1×107  14.3 13.5 
1×106  21.4 17.8 
1×105  29.6 23.5 
1×104  28.6 24.0 
1×103  30.0 29.3 
1×102  36.8 29.6 
1×101  38.7 35.4 
1×108  12.6 10.6 
1×107  14.3 13.5 
1×106  21.4 17.8 
Ct value: threshold cycle. rRT-PCR: real time reverse transcriptase 
polymerase chain reaction 
 
TABLE 3. Demographic data
 Controls  (N=60) Patients  (N=198)
Sex (male/female) 32/28  83/115 
Age (years) 32.60±10.44 38.09±15.00 
Diagnosis    
Major depressive disorder   98 
Bipolar I disorder    40 
Manic   33 
Depressed   07 
Schizophrenia   60 
Paranoid   41 
Undifferentiated   18 
Disorganized   01 
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used contaminated samples. The advantage of our study 
is that we used rRT-PCR which is the preferred methods 
to prevent cross-contamination. Because rRT-PCR could 
also have the possible risk of contamination, we specially 
paid attention to keep all the equipments cleaned and de-
contaminated. However, several studies have demonst-
rated that RT-PCR positive results were more frequent 
in patients than in controls.
46,47 The findings suggest that 
contamination cannot fully explain the discrepancies in 
conflict RT-PCR results. With regard to the seroepidemio-
logical study, the low avidity of human antibodies against 
BDV antigens compared to the high avidity of infected 
animal antibodies has raised the possibility that sero-
prevalence of BDV in humans might be the result of 
cross-reactivity.
48 Second, the negative results might have 
been derived from the area in which the BDV infection 
of the animal is not endemic. The fact that we have con-
sistently failed to demonstrate BDV infection in Korean 
psychiatric patients supports this notion.
37,38 However, 
the conflicting results regarding BDV infection cannot 
be attributed only to geographic factors. It has been re-
ported that BDV is not associated with psychiatric pa-
tients in Kyushu island in Japan, a known endemic area 
of BDV infection.
8,42,49 However, there have been two 
BDV-positive reports in Brazil, which has not been known 
to be an endemic BDV infection area.
23,24 Third, the pa-
thogenesis and symptoms of BDV infection in humans 
would be different from the infection in animals. Re-
cently, Matsunage et al.
50 have suggested that human in-
fection of BDV would be asymptomatic and non-patho-
genic. 
In conclusion, this study supports our previous results 
that BDV is not associated with psychiatric patients in 
Korea. However, it remains controversial whether BDV 
infection is associated with human psychiatric diseases. 
To clarify the presence of BDV in psychiatric patients, sub-
sequent studies with novel diagnostic tools are needed. 
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